Fate Therapeutics, Inc.FATENASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 31 | 56↑77.7% | 96↑72.4% | 64↓34.0% | 14↓78.5% |
| Gross Profit | -94 | 50↑153.1% | 83↑65.1% | -94↓213.5% | 14↑114.6% |
| Operating Income | -128 | -217↓69.4% | -308↓42.1% | -191↑38.2% | -210↓10.4% |
| Net Income | -173 | -212↓22.4% | -282↓32.8% | -161↑42.9% | -186↓15.7% |
| EBITDA | -125 | -211↓68.9% | -295↓39.5% | -172↑41.5% | -177↓2.5% |
| EPS Diluted | -2.10 | -2.24↓6.7% | -2.91↓29.9% | -1.64↑43.6% | -1.64↓0.0% |